November 21, 2011
Otsuka Pharmaceutical Co., Ltd.
Streptococcus pneumoniae Kit “RAPIRUN S. pneumoniae HS (otitis media/sinusitis)” as in vitro diagnostic releases on December 1
Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced the launch of "RAPIRUN S. pneumoniae HS (otitis media/sinusitis)", Streptococcus pneumoniae antigen detection reagent by the immunochromatographic method, as an in vitro diagnostic on December 1, 2011.
Information in this news release was current as of the original release date.